Kestra Showcases Accelerated Innovation at HRS 2026
Kestra Medical Technologies will exhibit its Cardiac Recovery System at Heart Rhythm 2026, showcasing innovations in managing sudden cardiac arrest risk. The event features the FDA-approved algorithm update for the ASSURE WCD, which enhances patient protection leveraging real-world data. CEO Brian Webster highlights the shift towards connected care in SCA risk management. Attendees can explore the platform and clinical data at Booth 2119.
KIRKLAND, Wash., April 22, 2026 (GLOBE NEWSWIRE) — Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today announced it will exhibit at Heart Rhythm 2026, the annual meeting of the Heart Rhythm Society (HRS) taking place April 23–26 in Chicago. The company will showcase its Cardiac Recovery System® platform—a modern, integrated approach to managing sudden cardiac arrest (SCA) risk that unites proven therapy, actionable clinical insights, and ongoing patient support to enhance protection and optimize care.